General Information of the Compound
Compound ID
CP0210512
Compound Name
CID6851947
    Show/Hide
Synonyms
PAC-1
PAC1
    Show/Hide
Structure
Formula
C23H28N4O2
Molecular Weight
392.503
Canonical SMILES
Oc1c(CC=C)cccc1\C=N\NC(=O)CN1CCN(Cc2ccccc2)CC1
    Show/Hide
InChI
InChI=1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+
    Show/Hide
InChIKey
YQNRVGJCPCNMKT-LFVJCYFKSA-N
CAS
315183-21-2
Physicochemical Property
logP
2.3886
Rotatable Bonds
8
Heavy Atom Count
29
Polar Areas
68.17
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135421197
SID: 17496224
ChEMBL ID
CHEMBL591429
DrugBank ID
DB13048
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01014, Caspase-3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000365 NCI-H226 Homo sapiens (Human)  1
1
IC50 = 350 nM
   TI
   LI
   LO
   TS
CL000018 HL-60 Homo sapiens (Human)  1
1
IC50 = 920 nM
   TI
   LI
   LO
   TS
CL000243 MCF-10A Homo sapiens (Human)  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CL000597 Hs 888.Lu Homo sapiens (Human)  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CL000083 MCF-7 Homo sapiens (Human)  1
1
IC50 > 75000 nM
   TI
   LI
   LO
   TS
CL000364 Hs 578T Homo sapiens (Human)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CL000366 UACC-62 Homo sapiens (Human)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 4080 nM
2 IC50 = 3200 nM
3 IC50 > 100000 nM
Clinical Information about the Compound
Drug 1 ( PAC1 )
Drug Name PAC1
Indication
Anaplastic astrocytoma
Phase 1
Recurrent glioblastoma
Phase 1
Target(s)
Caspase-3 (CASP3)
Activator